Where we heard itBloomberg TV, The China Show (ETF IQ Asia segment), Oct. 2, 2026. Speaker: David Mann, global head of ETFs and market structure at Franklin Templeton. Watch at Bloomberg
Franklin TempletonBEN has teamed up with China Asset Management (ChinaAMC), a mainland Chinese fund manager, on its first ETF listings in Asia: two Hong Kong funds that hold Hong Kong-listed and U.S. or other overseas stocks. David Mann, global head of ETFs and market structure at Franklin Templeton, described the debut on Bloomberg TV’s The China Show. David Mann said: “We launched the two funds… Both seeded with almost a combined $100 million.”

U.S. Investors Cannot Buy These Funds
Both funds are listed in Hong Kong. They are not available on any U.S. exchange.
One fund focuses on cash flow; the other targets innovative pharmaceuticals. The partner, ChinaAMC, is not listed in the United States.
A Small Launch for a $1.8 Trillion Manager
Franklin Templeton manages approximately $1.8 trillion in assets and had a market value of about $16.7 billion at the Oct. 2 close. David Mann put the seed money for the new funds at almost $100 million combined. A launch this size is a strategic positioning move, and it is too small to affect the parent’s financial results.
The firm was founded in 1947. It changed its corporate name from Franklin Resources to Franklin Templeton, Inc. effective August 17, 2026, and the ticker is still BEN.
The core business has momentum. The firm’s fiscal third-quarter earnings release reported $18.4 billion in long-term net inflows, compared with $9.3 billion in net outflows a year earlier. Adjusted diluted EPS was $0.72. On the earnings call, Chief Executive Jenny Johnson said active ETFs made up “61% of ETF net flows” at the firm.

How Mann Describes the Two Strategies
David Mann explained the cash-flow fund this way: “That is very simply quality companies where we think the cash is a good indicator of the financial strength of the company, maybe even compared to more like dividend payers.”
On the second fund, David Mann said: “Certainly from the innovative drugs, that’s biotech and health care. We think China is really pushing the envelope from an innovation perspective.”
Mann also said the firm already builds ETFs in three main hubs, the U.S., Canada and Europe’s UCITS market, and is looking at Japan and Singapore next.
Franklin’s ETF business before the launch
A Heavily Hedged Timeline for Mainland Access
David Mann described how the funds could join the Connect program, which links Hong Kong and mainland markets: “I believe it’s typically an AUM threshold, which then has, like, a six month window. So getting it launched before the end of the month hopefully puts us on track for, call it, roughly the end of Q1 next year.”
He hedged three times: “I believe,” “hopefully,” and “call it, roughly.” Inclusion would open the funds to a wider investor pool, but no date has been set.
Market Figures Mann Cited
David Mann of Franklin Templeton put Hong Kong ETF inflows at roughly $9 billion this calendar year. David Mann also said active ETFs account for 37% of U.S. net inflows, a trend he expects to reach Asia. Neither figure was independently verified for this article.
How BEN Shares Have Moved
Franklin Templeton shares closed at $32.81 on October 2, 2026, up 0.95% on the day. Including dividends, the stock returned 42.2% this year and 50.3% over the past year. On price alone it is up 37.3% this year and 43.2% over the past year. Over five years the total return is 39.8%, and over ten years it is 52.3%.

Most of the gain came between a November 2025 low of $21.18 and an August 2026 high of $35.77. The shares have slipped about 8% since that high, and nothing here establishes a cause.
What Investors Should Watch Next
The launch shows where asset managers see growth. For U.S. readers, it is something to follow from a distance, since the funds trade only in Hong Kong. Three things to track:
- Whether the funds reach the asset threshold Mann described.
- Whether Franklin Templeton follows through on expanding elsewhere in Asia.
- Whether demand for active ETFs actually goes into the region, as he forecasts.
Mann sees China’s drug innovators and cash-rich companies as themes Asian investors want, and he hopes the two Hong Kong funds reach mainland buyers around the end of the first quarter. The funds start small, almost $100 million against $1.8 trillion, and that timeline rests on an asset threshold he hedged three times.